Systemic lupus erythematosus (SLE) and other autoimmune diseases often involve a response to immune complexes containing DNA or chromatin-associated proteins. A new study published in Immunity has now ...
Biochemical recurrence endpoints did not reliably predict overall survival in prostate cancer trials. Treatments that reduce the risk for biochemical recurrence (BCR) do not necessarily improve ...
The Bcr/Abl fusion protein is the product of the Philadelphia (Ph) chromosome, itself the result of a reciprocal translocation between chromosomes 22 and 9. The fusion of Bcr with the Abl tyrosine ...
JACKSONVILLE, Fla.--(BUSINESS WIRE)--BCR today announced it will be rolling out a major repositioning and brand refresh this Spring which parallels a recently announced expansion to provide its ...
Cyclophosphamide, Thalidomide, and Dexamethasone as Initial Therapy for Patients With Newly Diagnosed Multiple Myeloma in a Middle-Income Country: 7-Year Follow-Up A total of 962 cases of CML on ...
Measuring biochemical recurrence (BCR) as a surrogate marker produces unreliable results as a primary end point for overall survival of patients with localized prostate cancer, a study found. In a ...
BCR-ABL is a constitutively activated tyrosine kinase that causes chronic myeloid leukemia (CML). Since tyrosine kinase activity is essential to the transforming function of BCR-ABL, an inhibitor of ...
Banco de Costa Rica (BCR) has now confirmed that a file leaked by ransomware group Maze contains personal credit and debit card information. In an interview with La Nación, representatives from the ...
BCR Announces Strategic Partnership to Bring Leading Belt Dryer Brand SEVAR to North American Market
JACKSONVILLE, Fla.--(BUSINESS WIRE)--BCR Inc, a leading provider of proven biosolids and process treatment technology solutions, announced today a strategic partnership with leading Germany-based belt ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results